Conmed Corp (CNMD) Tops Q3 EPS by 2c; Tightens FY11 EPS Range; Guides Q4 Below
Conmed Corp (NASDAQ: CNMD) reported Q3 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $172.8 million versus the consensus estimate of $178.49 million.
Conmed Corp sees Q4 2011 EPS of $0.37-$0.42, versus the consensus of $0.43. Conmed Corp sees Q4 2011 revenue of $183-$187 million, versus the consensus of $192.41 million.
Conmed Corp sees FY2011 EPS of $1.42-$1.47, versus prior guidance of $1.40-$1.50 and the consensus of $1.45. Conmed Corp sees FY2011 revenue of $722-$727 million, versus prior guidance of $735-$740 million and the consensus of $739.30 million.
Conmed Corp sees Q4 2011 EPS of $0.37-$0.42, versus the consensus of $0.43. Conmed Corp sees Q4 2011 revenue of $183-$187 million, versus the consensus of $192.41 million.
Conmed Corp sees FY2011 EPS of $1.42-$1.47, versus prior guidance of $1.40-$1.50 and the consensus of $1.45. Conmed Corp sees FY2011 revenue of $722-$727 million, versus prior guidance of $735-$740 million and the consensus of $739.30 million.